Cargando…
Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis
Human Leukocyte Antigen (HLA) variants can be a risk factor for developing potentially fatal drug hypersensitivity reactions. Our aim was to estimate the potential impact of genotyping for the HLA risk alleles incorporated in the Dutch Pharmacogenetics Working Group (DPWG) guidelines in The Netherla...
Autores principales: | Manson, Lisanne E. N., van den Hout, Wilbert B., Guchelaar, Henk-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781874/ https://www.ncbi.nlm.nih.gov/pubmed/35056062 http://dx.doi.org/10.3390/ph15010004 |
Ejemplares similares
-
Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
por: Manson, Lisanne E. N., et al.
Publicado: (2020) -
Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
por: Manson, Lisanne E. N., et al.
Publicado: (2023) -
Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions
por: Manson, Lisanne E. N., et al.
Publicado: (2022) -
Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model
por: van der Wouden, Cathelijne H., et al.
Publicado: (2022) -
HLA alleles associated with asparaginase hypersensitivity in Chinese children
por: Chua, Gilbert T., et al.
Publicado: (2021)